Condition (MeSH)
Spider Bites
ClinicalTrials.gov lists 4 trials for Spider Bites or a narrower condition beneath it. Instituto Bioclon S.A. de C.V. has the most among industry and government lead sponsors, with 2.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
4 of the 4 trials are tagged with Spider Bites itself; the rest are tagged with a narrower condition beneath it.
When did Spider Bites trials start? (4)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 2
- Phase 3
- Observational
Top of scale: 1
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2021 | 1 |
| 2011 | 1 |
| 2009 | 1 |
| 2005 | 1 |
No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 4 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Spider Bites trials in? (4)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
| Phase 3 | 1 |
| Observational | 1 |
How many Spider Bites trials are recruiting? (1)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Completed | 4 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Spider Bites trials? (2)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Instituto Bioclon S.A. de C.V. | 2 |
| Laboratorios Silanes S.A. de C.V. | 1 |
Which serious adverse events do Spider Bites trials report? (2)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Cellulitis | 1 | 1 |
| Inadequate Pain Control | 1 | 1 |
Which publications cover Spider Bites? (6)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| The Efficacy of Antivenin Latrodectus (Black Widow) Equine Immune F(ab')<sub>2</sub> Versus Placebo in the Treatment of Latrodectism: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial. | Annals of emergency medicine | 2019 | Yes |
| Treatments for Latrodectism-A Systematic Review on Their Clinical Effectiveness. | Toxins | 2017 | Yes |
| Swiss prospective study on spider bites. | Swiss medical weekly | 2013 | Yes |
| Envenoming and antivenom use in Australia. | Toxicon : official journal of the International Society on Toxinology | 1998 | Yes |
| Lymphatic flow rates and first-aid in simulated peripheral snake or spider envenomation. | The Medical journal of Australia | 1994 | Yes |
Showing 5 of 6 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.